Nizar Bitar
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 3
-
- Pneumonia and Respiratory Infections 2
- Co-authors
- Frédéric A. Meunier (1 shared paper)Mabel Aoun (1 shared paper)Ali Shamseddine (9 shared papers)Eva Hamade (2 shared papers)Mohammad Fayyad‐Kazan (2 shared papers)Bassam Badran (2 shared papers)Hussein Fayyad‐Kazan (2 shared papers)Ahmad Daher (1 shared paper)
In The Last Decade
Nizar Bitar
27 papers receiving 537 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 138
- Infectious Diseases 115
- Oncology 101
- Hematology 39
- Obstetrics and Gynecology 24
Countries citing papers authored by Nizar Bitar
This map shows the geographic impact of Nizar Bitar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nizar Bitar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nizar Bitar more than expected).
Fields of papers citing papers by Nizar Bitar
This network shows the impact of papers produced by Nizar Bitar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nizar Bitar. The network helps show where Nizar Bitar may publish in the future.
Co-authors
The 25 scholars most cited alongside Nizar Bitar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 142 | |
| 2 | 1992 | 139 | |
| 3 | 1999 | 42 | |
| 4 | 2011 | 37 | |
| 5 | 2022 | 28 | |
| 6 | 2013 | 21 | |
| 7 | 2003 | 20 | |
| 8 | 1989 | 20 | |
| 9 | 2019 | 15 | |
| 10 | Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemia. | 1987 | 14 |
| 11 | 2010 | 12 | |
| 12 | 2019 | 11 | |
| 13 | Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis. | 2015 | 11 |
| 14 | 2009 | 10 | |
| 15 | Eosinophilic fasciitis and severe aplastic anemia: favorable response to either antithymocyte globulin or cyclosporine A in blood and skin disorders. | 1988 | 8 |
| 16 | 2009 | 6 | |
| 17 | 2005 | 4 | |
| 18 | 2025 | 2 | |
| 19 | 2020 | 2 | |
| 20 | 2006 | 2 |
About Nizar Bitar
Nizar Bitar is a scholar working on Oncology, Epidemiology, Molecular Biology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 32 papers that have together received 558 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Eosinophilic Disorders and Syndromes (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Lung Cancer Treatments and Mutations (3 papers), Pneumonia and Respiratory Infections (2 papers), Parvovirus B19 Infection Studies (2 papers) and T-cell and Retrovirus Studies (2 papers). The work is most often cited by research in Cancer Research (138 citations), Infectious Diseases (115 citations), Oncology (101 citations), Hematology (39 citations) and Obstetrics and Gynecology (24 citations). Nizar Bitar has collaborated with scholars based in Lebanon, Belgium and France. Frequent co-authors include Frédéric A. Meunier, Mabel Aoun, Ali Shamseddine, Eva Hamade, Mohammad Fayyad‐Kazan, Bassam Badran, Hussein Fayyad‐Kazan, Ahmad Daher, Mehdi Najar and Philippe Martiat. Their work appears in journals such as Journal of Clinical Oncology, Clinical Breast Cancer, ESMO Open, Regulatory Toxicology and Pharmacology and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.